Roche Holding AG is extremely optimistic that its latest experimental Alzheimer’s drug will deliver a benefit for patients, Chief Executive Officer Thomas Schinecker said, despite a track record of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback